Introduction
A plasma lipopolysaccharide (LPS)-binding protein (LBP) has been shown to regulate the response of rabbit peritoneal macrophages and human blood monocytes to endotoxin (LPS). We investigated whether LBP is present in lung fluids and the effects of LBP on the response of lung macrophages to LPS. Immunoreactive LBP was detectable in the lavage fluids of patients with the adult respiratory distress syndrome by immunoprecipitation followed by Western blotting, and also by specific immunoassay. In rabbits, the LBP appeared to originate outside of the lungs, inasmuch as mRNA transcripts for LBP were identified in total cellular RNA from liver, but not from lung homogenates or alveolar macrophages. Purified LBP enhanced the response of human and rabbit alveolar macrophages to both smooth form LPS (Escherichia coli 0 1 1B:4) and rough form LPS (Salmonella minnesota Re595). In the presence of LBP and LPS, the onset of tumor necrosis factor-a (TNFa) production occurred earlier and at an LPS threshold dose that was as much as 1,000-fold lower for both types of LPS. In rabbit alveolar macrophages treated with LBP and LPS, TNFa mRNA appeared earlier, reached higher levels, and had a prolonged half-life as compared with LPS treatment alone. Neither LPS nor LPS and LBP affected pH, or ICa"]I in alveolar macro- phages. Specific monoclonal antibodies to CD14, a receptor that binds LPS/LBP complexes, inhibited TNFa production by human alveolar macrophages stimulated with LPS alone or with LPS/LBP complexes, indicating the importance of CD14 in mediating the effects of LPS on alveolar macrophages. Thus, immunoreactive LBP accumulates in lung lavage fluids in patients with lung injury and enhances LPS-stimulated TNFa gene expression in alveolar macrophages by a pathway that depends on the CD14 receptor. LBP may play an important role in augmenting TNFa expression by alveolar macrophages within the lungs. (J. Clin. Invest. 1992. 90:2209-2219.) Key words: alveolar macrophages * CD14 receptor * endotoxin * endotoxin binding protein * tumor necrosis factor Lipopolysaccharide (LPS) binding protein (LBP)' is a glycoprotein that is present in the plasma of normal animals and humans ( 1, 2) . During acute-phase reactions, the plasma concentration of LBP rises by > 10-fold. In rabbits, LBP is produced in hepatocytes as a 50-kD protein that is glycosylated before secretion and circulates as a 60-kD glycoprotein (3) .
Previous studies have indicated that the LBP molecule contains a high-affinity binding site that binds the lipid A portion ofLPS with 1:1 stoichiometry and Kd's in the nanomolar range (4) . LBP opsonizes LPS-bearing particles, enhancing their association with the surface ofmonocyte-derived macrophages (5) . Binding of LPS/LBP complexes to monocytes occurs via the CD 14 antigen, which is present on monocytes, macrophages, and stimulated PMN (6) .
Several lines of evidence suggest that LBP may play an important role in the host response to endotoxin. LBP lowers the threshold concentration at which LPS from smooth and rough forms ofbacteria initiate the secretion oftumor necrosis factora (TNFa) by cells of the monocyte/macrophage lineage (7) . Immunodepletion of LBP from normal rabbit plasma markedly attenuates LPS-induced TNFa production in rabbit whole blood (7) . Antibodies to the CD14 receptor on monocytes block the TNFa production in human whole blood in response to LPS (6) . Transfection of CD14 into the murine pre-B cell line 70Z/ 3 enhances IgM surface expression in response to LPS and LBP by several orders of magnitude (8) . Thus, the LBP/CD14-dependent pathway appears to play an important role in mediating LPS-induced cytokine production by monocytic cells.
Our goal in the present study was to determine the potential relevance of this LBP/CD 14 pathway for inflammatory reactions in the lungs. Normally, the lung airspace is isolated from the plasma compartment by a relatively impermeable epithelial barrier. During acute lung injury, such as that which occurs in patients with the adult respiratory distress syndrome (ARDS), the epithelial barrier is damaged and permeability increases markedly, allowing the movement ofplasma proteins into the alveolar spaces (9) . In these patients, production of cytokines such as TNFa in the lungs during lung injury may contribute to local and systemic manifestations of disease. Therefore, we investigated two questions: first, whether LBP is 1. Abbreviations used in this paper: ARDS, adult respiratory distress syndrome; BCECF/AM, 2',7'-bis-(2-carboxyethyl)-5-(and-6 )carboxyfluorescein acetoxymethyl ester; LBP, lipopolysaccharide binding protein; SPF, specific pathogen free; TNFa, tumor necrosis factor-a. present in the alveolar spaces normally or when epithelial permeability is altered by acute lung injury; and second, whether LBP augments LPS-induced TNFa production by rabbit and human alveolar macrophages.
Methods
Reagents. Rabbit LBP was isolated from acute-phase rabbit serum as previously described ( 1) . The final LBP preparation was sterile by culture on blood agar and gave a negative reaction for endotoxin contamination in a chromogenic limulus assay (Whittaker M.A. Bioproducts, Boston, MA). The LBP was aliquotted and stored frozen at -70'C before use. Endotoxin preparations (LPS) from Salmonella minnesota Re595 (List Biologicals, Campbell, CA) and Escherichia coli OJJll:B4 (Sigma Chemical Co., St. Louis, MO) were solubilized at 5 mg/ml in 10 mM EDTA by sonication, aliquotted, and stored frozen at -70'C. For each assay, an aliquot of stock LPS was thawed, sonicated for lO s, and then diluted to the appropriate concentrations in 0.9% NaCl containing 10 mM Hepes buffer. Murine monoclonal antibodies 3c10 (anti-CD14) and 60.3 (anti-CD18) were the respective gifts of Wes Van Voorhis, Seattle, WA and Pat Beatty, Seattle WA. Murine monoclonal antibodies 28C5 (anti-CD 14) , 1E8 (anti-LBP), and 18G4 (anti-LBP) were generated by Didier LeTurcq from recombinant human soluble CD14 and recombinant human LBP.
Measurement ofLBP in lung lavagefluids. Bronchoalveolar lavage fluid was obtained as described from two healthy volunteers who were free of lung disease (10) and from six patients with ARDS who were mechanically ventilated ( 11) . ARDS was defined as the presence of critical hypoxemia on supplemental oxygen, diffuse pulmonary infiltrates, normal pulmonary capillary wedge pressure, and no other obvious cause for these findings. Lavage fluids from normal volunteers and patients with ARDS were stored frozen (-70°C) until analyzed.
Immunoreactive LBP was measured in bronchoalveolar lavage fluid from normal volunteers and patients with ARDS using two different methods: immunoprecipitation and enzyme immunoassay. LBP was immunoprecipitated using polyclonal anti-rabbit LBP antibody prepared by immunizing goats or rats with purified rabbit LBP as described (1). Aliquots (850 ,l) of the six ARDS and the two normal lavage fluids were mixed with undiluted goat anti-rabbit LBP antiserum ( 150 ,ul) ( 15% vol/vol) and incubated overnight at 4°C. This antiserum concentration had previously been shown to give optimal immunoprecipitation results ( 1 ) . To test the reproducibility of the results, the two ARDS lavage fluids with the highest protein concentrations (nos. 4 and 6) were also incubated with a rat anti-rabbit LBP antibody. After the overnight incubation, the fluids were spun at 12,000 g in a microcentrifuge at 4°C for 30 min to pellet the precipitates. The precipitates were washed once in buffer containing 150 mM NaCl, 50 mM Hepes, 0.2% Tween-20 (Bio-Rad Laboratories, Richmond, CA), then sonicated for 60 s, and respun at 12,000 gfor 60 min. The resulting precipitates were washed again in H20 and respun for an additional 60 min. The final precipitates were resuspended in Laemmli reducing buffer containing 5% f,-mercaptoethanol and heated at 72°C for 30 min, then at 100°C for 2 min. The proteins were resolved by electrophoresis through 10% SDS-polyacrylamide gels and transferred to nitrocellulose membranes by electroblotting for 12 h at 4°C. The nitrocellulose membranes were incubated overnight in blocking buffer containing 1% gelatin, 3% bovine serum albumin, 0.05% Tween-20 and then reacted with purified goat anti-rabbit LBP ( 1:400 dilution) for 2 h at 21 'C. The membranes were washed, incubated with recombinant '251-protein G (New England Nuclear, Boston, MA) for 30 min, washed thoroughly, and analyzed by autoradiography overnight at -70°C using XOMAT-AR film (Eastman Kodak Co., Rochester, NY).
LBP also was measured quantitatively in the same bronchoalveolar lavage fluids by enzyme immunoassay using murine monoclonal antibodies raised to purified human LBP. Microtiter plate wells were coated overnight with a murine monoclonal anti-LBP antibody ( 1E8), then washed three times and blocked with casein. Lavage fluids (200 Ml) were added to each well and incubated for 1 h at 371C. The wells were washed twice and incubated with a different biotinylated murine monoclonal anti-LBP antibody (18G4). The wells were washed again and the signal was developed by incubating with streptavidin-biotin-horseradish peroxidase complex for 30 min at 370C, followed by o-phenylenediamine for 30 min and then 4.0 N H2SO4 to stop the reaction. The LBP concentration was determined by measuring the OD 490 nm in each well and comparing the results with a standard curve using purified human LPB. The assay is linear over the range of 30-250 ng LBP per well.
Cell recovery. Human alveolar macrophages were recovered by bronchoalveolar lavage from normal human volunteers who gave written informed consent as previously described (10) . Briefly, the oropharynx was anesthetized with topical lidocaine and a flexible fiberoptic bronchoscope (model FBI5A; Pentax Precision Instrument Co., Orangeburg, NJ) was passed into the lower airway. Single subsegments of both the right middle lobe and the lingula were lavaged with five separate 30-ml aliquots of sterile pyrogen-free 0.9% NaCl and each aliquot was recovered by gentle suction. The cells were recovered by centrifugation and the lavage fluids were cultured quantitatively on blood agar to assess the degree of bacterial contamination. The cells were washed twice in LPS-free RPMI-1640 media (Whittaker M.A. Bioproducts) containing 10 mM Hepes buffer, 2mM L-glutamine, 100 U/ml penicillin, 100 Mg/ml streptomycin, and 50 ug/ml gentamicin (complete RPMI-1640), counted, and suspended in complete RPMI-1640 media at 1 X 106 alveolar macrophages/ml before use in the assays.
Rabbit alveolar macrophages were recovered from specific pathogen-free (SPF) rabbits by bronchoalveolar lavage. Female rabbits weighing 1.5-2.0 kg were obtained from Western Oregon Rabbitry, Eugene, OR and monitored in the vivarium of the Seattle VA Medical Center for 1 wk before use. The rabbits were anesthetized deeply with intravenous pentobarbital and then exsanguinated by closed cardiac puncture. The thorax was opened and the lungs were lavaged in situ at a transpulmonary pressure of -20 cm H20 with five separate 50-ml aliquots of sterile, pyrogen-free 0.9% NaCl containing 0.6 mM EDTA. The lavage aliquots from each animal were pooled and the cells were pelleted by centrifugation at 200 g for 15 min. The cells were washed twice in complete RPMI-1640. Total cell counts were performed in a hemacytometer. Differential counts were performed on cytospin preparations stained with a modified Wright Giemsa stain (Diff-Quik, Scientific Products Co., McGaw Park, IN). Aliquots of the fresh lavage fluids (10 and 100 ul) were cultured quantitatively on blood agar to assess sterility. We used SPF rabbits because preliminary studies showed that the bronchoalveolar lavage fluids of non-SPF rabbits often were contaminated with low numbers of Gram-negative bacteria. The lavage fluids of the SPF animals were almost always sterile. Only alveolar macrophages from SPF animals with sterile lavage fluids were used in these studies.
Recovery oftotal cellular RNA and Northern blotting analysis. Total cellular RNA was recovered from rabbit alveolar macrophages by CsCl density gradient centrifugation using modifications of previously described methods ( 12, 13) . Briefly, alveolar macrophages were lysed in a buffer containing 4.0 M guanidine thiocyanate, 25 mM trisodium citrate, 0.5% sodium laroyl sarcosine, 10 mM EDTA, 0.7% 2-mercaptoethanol, and 0.33% antifoam A (Sigma Chemical Co.). The lysates were underlayered with 5.7 M CsCl and centrifuged for 12 h at 1 10,000 g in an ultracentrifuge using either a TiSO or a Ti75 rotor (Beckman Instruments Inc., Palo Alto, CA). The RNA pellets were solubilized in 10 mM Tris/0. 1 mM EDTA and purified by phenol-cloroform extraction followed by precipitation in 70% ethanol/0.3 M sodium acetate. The RNA concentration was measured by spectrophotometry at 260 nM. The recovery of total RNA averaged -3-5 ug ofRNA/ 106 alveolar macrophages. The total cellular RNA ( 15 ,g per lane) was denatured in 1 M glyoxal containing 50% DMSO and 10 mM sodium phosphate and electrophoresed through 1.2% agarose for 12 h at 1.0 V/cm. The quality of the RNA was assessed routinely by staining the gels in 0.01% acridine orange and examining the 28 S ( 12) . The resulting hybridized membranes were developed by autoradiography at -70'C for up to 24 h using an intensification screen and Kodak X-OMAT AR film. The Northern analyses were quantified either directly using an automated phosphor-imaging system (PhosphorImager 400A Molecular Dynamics, Sunnyvale, CA) to count the radioactivity ofeach individual lane ( 14) , or indirectly by performing videodensitometry of the images on the exposed xray film (Visage 2000, Bio Image Products, Millipore Corp., Ann Arbor, MI).
Localization ofLBP mRNA in tissue specimens using polymerase chain reaction (PCR). To determine the cellular localization ofmRNA for LBP, we used the polymerase chain reaction to amplify mRNA transcripts for LBP in total cellular RNA from rabbit liver, lung, and alveolar macrophages. A localized inflammatory reaction was produced in a normal SPF rabbit by injecting 1.0 ml of 3% AgNO3 (wt/wt) in sterile pyrogen-free water subcutaneously between the shoulder blades as described ( 1) . The animal was then killed 20 h later. The liver was removed aseptically and a portion was minced and immersed immediately into ice cold lysis buffer. The lungs were lavaged as described, and then slices ofthe left lower lobe were placed in ice cold lysis buffer. The lavage cell pellets were washed twice and then lysed in cold lysis buffer. The liver and lung slices were homogenized in cold lysis buffer, and then the total cellular RNA was recovered from the liver, lung and alveolar macrophage specimens as described above. The presence of LBP mRNA transcripts was analyzed with the PCR using the GeneAmp method (Perkin Elmer Cetus, Norwalk CT). The RNA was reverse transcribed using M-MLV reverse transcriptase, then amplified using AmpliTaq DNA polymerase in the presence ofa sense/antisense primer pair specific for the coding region of the rabbit LBP cDNA sequence (predicted size 299 bases). For comparison, we used a sense/ antisense primer pair specific for the coding sequence ofthe rabbit IL8 cDNA (predicted size 306 bases) because IL-8 mRNA is known to be produced in liver ( 15) and alveolar macrophages ( 16). The rabbit IL8 cDNA was isolated from a cDNA library that we had prepared from LPS-stimulated rabbit alveolar macrophages and had a coding sequence identical to that reported for rabbit IL-8 cloned from rabbit splenocytes ( 17) . The cycling protocol consisted ofmelting at 94°C for 1 min, annealing at 55°C for 2 min, and extending at 720 for 3 min.
After 30 amplification cycles, the reaction products were subjected to electrophoresis in 6% acrylamide and visualized by staining with ethidium bromide. The PCR reactions were performed simultaneously using RNA from the acute-phase rabbit liver, lungs, and alveolar macrophages. Additional tubes were included using RNA recovered from normal rabbit alveolar macrophages incubated for 4 h in the presence or absence of 1 ng/ml Re595 LPS. This concentration of LPS was chosen because it was shown to produce marked accumulation ofcytokine mRNA at 4 h (TNFa).
The identities of the LBP and IL8 PCR products were verified in three ways. First, the PCR products gave bands ofthe predicted size on polyacrylamide gel electrophoresis. Second, restriction digestion ofthe PCR products using restriction enzymes with sites within the predicted target sequences gave digestion products of exactly the predicted size. Third, the PCR products were cloned into the plasmid vector PCR1000 (In Vitrogen Co, San Diego, CA), which was then inserted into E. coli by electroporation. The plasmid was then harvested and the insert was sequenced using the Sequenase reaction system (U.S. Biochemical Corp., Cleveland, OH). The observed sequences ofthe rabbit LBP and IL-8 inserts matched the known base sequences of the predicted target sequences.
When the PCR primers were used to amplify the rabbit liver RNA preparations without first conducting the reverse-transcription step, no signal for LBP was detected, making it unlikely that trace amounts of genomic DNA that might have been present in the samples could have been the target of the amplification reaction.
Measurement of TNFa. TNFa was measured in a cytotoxicity assay using the L929 cell line as described ( 12, 18) . L929 cells were suspended in RPMI media containing 10 mM Hepes, 2 mM L-glutamine, penicillin ( 100 U/ml), streptomycin ( 100 Mg/ml), and actinomycin D ( 1.0 Ag/ml) and aliquotted in 96-well microtiter plates at 2
x 10' per well. The cells were allowed to adhere to the plates for 2 h at 370C in 5% Co2. Then aliquots of each sample (5 ,ul) were added to duplicate wells and titered by serial threefold dilutions. After incubation for 18 h at 370C/5% C02, the residual cells were fixed and stained with 0.2% crystal violet/3.7% formalin, and the absorbance in each well was measured spectrophotometrically (model MR5000, Dynatech Labs, Inc., Chantilly, VA). The cytolytic activity in each sample was quantitated by comparing the half-maximal lytic concentration in the samples with that in wells containing serial threefold dilutions of a standard of known TNFa activity prepared from LPS-treated RAW 264.7 cells (5 x I04 U/ml). The TNFa activity in the RAW cell standard was calibrated using a human recombinant TNFa standard obtained from the National Institute for Biological Standards and Control, Hertfordshire, UK.
Measurement of CD14 expression on alveolar macrophages and blood monocytes. We measured the expression ofthe CD 14 receptor on the surface of human alveolar macrophages (1 X 106 cells/ml in complete RPMI-1640 media) stimulated with LPS with or without added LBP. For comparison, peripheral blood mononuclear cells were recovered on the same day by density gradient centrifugation (Mono-poly Resolving Medium, Flow Laboratories, Inc., Costa Mesa, CA) from the same volunteers who underwent bronchoalveolar lavage and treated in the same manner as the alveolar macrophages. The alveolar macrophages and blood mononuclear cells were incubated in 1.5 ml polypropylene tubes (to minimize adherence) with 011l:B4 LPS (10 ng/ml) with or without LBP (100 ng/ml) at 37°C in 5% C02/air for 4 h. CD 14 was measured by indirect immunofluorescence using the murine antibody My4 (Coulter Laboratories, Hialeah, FL) as the primary antibody and goat anti-mouse IgG as the detecting antibody (phycoerythrin conjugate, Accurate Chemical & Scientific Corp., Westbury, NY). For comparison, the cells were labeled with murine 60.3, which labels CD 18 (19) . The alveolar macrophages and blood mononuclear cells were washed twice, suspended at 5 X 106/ml in HBSS containing 0.1 % bovine serum albumin and 0.1 % NaN3, and incubated on ice for 30 min with the primary antibody at a dilution of 1:100, followed by a 30-min incubation with the secondary antibody at a dilution of 1:500. After the labeling procedure, the cells were washed and then analyzed using a FACS Scan instrument (Becton Dickinson & Co., Mountain View, CA) with the gatings set to identify monocytes and macrophages.
Measurement ofintracellular pH and calcium. Intracellular pH in rabbit alveolar macrophages was measured using the fluorescent intracellular probe, 2',7'-bis-(2-carboxyethyl)-5-(and-6)carboxyfluorescein (BCECF; Molecular Probes, Inc., Eugene, OR) (20) . Alveolar macrophages were suspended at 1.5 X 106/ ml in complete RPMI 1640 and loaded with 0.5 MM BCECF/acetoxymethyl (AM) ester for 1 h at 37°C, washed twice, and resuspended in buffer containing 140 mM NaCl, 5 mM KCl, 1.8 mM CaCl2, 0.8 mM MgSO4, 5 mM glucose, 20 mM Hepes, and then placed in a quartz cuvette in a model LS5B fluorescence spectrometer (Perkin Elmer Corp., Norwalk, CT) equipped with a thermostatically controlled water-jacketed cell holder (37°C). The excitation wavelength was set at 505 nm and emission was scanned between 510 and 600 nm at 3-min intervals before and after the addition ofLPS or LBP. The height ofthe emission peak at 530 nm was recorded at each time. The height ofthe 530 nm peak decreases as pH falls. The system was calibrated over the pH range 6.5-8.0 by incubating alveolar macrophages in calibrating buffers of known pH containing 25 (22) .
Values for Rma, and Rmin were determined from additional macrophages incubated with ionomycin (5 gg/ml) to increase intracellular calcium, or ionomycin with EGTA to minimize intracellular calcium, as described (22) . This method is sensitive to changes of -20 nM in intracellular free calcium concentration.
Results
Detection ofLBP in lungfluids. To determine whether LBP is present in the airspaces ofnormal or inflammed lungs, we studied bronchoalveolar lavage fluids from two normal volunteers and six subjects with acute lung injury, ARDS. The characteristics ofthe lavage fluids are shown in Table I . The normal fluids contained > 90% viable alveolar macrophages and had protein concentrations of 10.4 and 9.2 mg/dl. In contrast, the lavage fluids of the patients with ARDS contained an abundance of neutrophils (range 17.5-95%) and five of the six contained an increased total protein concentration (range 7.6-244.9 mg/ dl). These findings are consistent with prior observations in patients with severe lung injury (9, 11) .
Equal volumes of the lavage fluids (850 MlI) were subjected to immunoprecipitation with goat anti-rabbit LBP polyspecific antisera and the precipitates were analyzed by SDS-PAGE and Western blotting using polyspecific -goat anti-LBP antiserum. For comparison we also immunoprecipitated the two fluids with the highest proteins using a different polyspecific anti-rabbit LBP antiserum raised in rats. The results are shown in Fig. 1 . A small amount of immunoreactive LBP was detectable in the lavage fluids of the two normal volunteers (lanes 7 and 8) and in the ARDS fluids with low protein concentrations (patients 2 and 5, lanes 2 and 5). In contrast, greater amounts of immunoreactive LBP were present in the lavage fluids ofthe patients with ARDS with the higher protein concentrations (patients 1, 3, 4, and 6 shown in the corresponding lanes). Immunoprecipitation ofthe lavage fluids from patients 4 and 6 with the goat and the rat anti-LBP antibodies gave similar immunoprecipitation results (Fig. 1, lanes 4 and 6 vs. 9 and 10). Immunoreactive bands of lower molecular weight were not detected in the lavage fluids, suggesting that the immunoreactive LBP detected by this method had not been degraded in the lungs by proteolytic cleavage. Table I . The lavage fluids were incubated at 40 overnight with 15% (vol/vol) goat or rat anti-rabbit LBP antibody. The precipitates were subjected to SDS-polyacrylamide gel electrophoresis under reducing conditions, electroblotted to a nitrocellulose membrane, and incubated with a different goat anti-rabbit LBP antibody, followed by "3'I-protein G. Lanes 1-8 show the results of lavage fluids precipitated with goat anti-rabbit LBP antibody. Lane 11 shows 100 ng/ml purified rabbit LBP immuno-precipitated with this same antibody. Lanes 9 and 10 show the results of precipitating ARDS fluids from the two patients shown in lanes 4 and 6 (ARDS patients 4 and 6) with a rat anti-rabbit LBP antibody. Lane 12 shows the results of precipitating 100 ng/ml purified rabbit LBP with this antibody. All of the immunoprecipitations were performed at the same time under the same conditions. The arrow indicates 60 kD. Measurement of immunoreactive LBP by immunoassay using these same lavage fluids gave results that supported the immunoprecipitation experiments, although the immunoassay was less sensitive than the immunoprecipitation. The levels of LBP were at or below the detection limit of this assay ( -40 ng/ml) in the two normal fluids (Fig. 1, lanes 7 and 8) and in the fluids that gave the lightest bands by immunoprecipitation (Fig. 1, lanes 1, 2, and 5) . The fluids from subjects 3, 4, and 6 contained 150, 600, and 120 ng/ml LBP, respectively.
Tissue localization ofLBP mRNA. To determine whether LBP might be produced in lung cells, we used the PCR method to identify mRNA transcripts coding for LBP in total cellular RNA from rabbit lung homogenate, rabbit alveolar macrophages, and rabbit liver, where LBP is known to be produced (3) (Fig. 2) . Liver mincings, lung mincings, and alveolar macrophages were recovered from a rabbit 24 h after the subcutaneous injection of 1.0 ml of 3% AgNO3 to induce an acute phase response. For comparison, we studied RNA derived from normal rabbit alveolar macrophages (Fig. 2 , lanes 7 and 8) and rabbit alveolar macrophages that were incubated for 4 h with 1 ng/ml Re595 LPS (Fig. 2, lanes 9 and 10) . This concentration of LPS is sufficient to cause marked accumulation of cytokine mRNA by 4 h. As seen in Fig. 2 , a product with the expected size ofthe LBP target sequence (299 bp) amplified in the rabbit liver RNA, but not in the RNA from the rabbit lung mincings or the alveolar macrophages. Direct sequencing of this PCR product proved that it had the expected LBP sequence. The LBP product also was not detected in the RNA of rabbit alveolar macrophages that had been incubated for 4 h with LPS. By contrast, the IL-8 product of the expected size (306 bp) was detected in liver, lung, and alveolar macrophages.
Effect ofLPS and LPS/LBP on TNFa production by human and rabbit alveolar macrophages. As LBP accumulates in lung fluids during acute lung injury, we next examined the dose and time dependency for LPS-induced TNFa release from human and rabbit alveolar macrophages in the presence and absence of purified rabbit LBP. R-form (Re595) and S-form (O1 1:B4) LPS were added to rabbit alveolar macrophages in concentrations ranging from 10 pg to 1 ,ug/ ml in the absence or presence of a constant ratio of purified rabbit LBP ( 12:1 LBP/ LPS, wt/wt). The TNFa present in the cell free supernatants was measured at 4, 8, or 16 h after the addition of LPS and LBP. The data shown in Fig. 3 demonstrate that the addition of LBP lowered the threshold dose of both forms of LPS by up to 1,000-fold and also accelerated the rate of TNFa production. This effect was detectable 4 h after stimulation of the macrophages and was still present at 16 h. In the absence ofLPS, LBP did not cause the release of any detectable TNFa from the alveolar macrophages. Heating the LBP to 90°C for 15 min destroyed the ability of the preparation to enhance the effect of LPS. Neither bovine serum albumin (10 utg/ml) nor rabbit IgG (10 ,ig/ml) affected the LPS dose response for TNFa production by rabbit alveolar macrophages.
The addition ofpurified rabbit LBP to human alveolar macrophages together with Re595 LPS produced effects similar to those noted for rabbit alveolar macrophages (Fig. 4) . In the absence of LBP, the threshold for TNFa production was -1.0 ng/ ml for Re595 LPS. In the presence ofLBP, the threshold for TNFa production in response to Re595 LPS was lowered to between 10 and 100 pg/ml for Re595 LPS and the rate of TNFa production was increased. The maximal TNFa concentrations produced by human alveolar macrophages treated The PCR reactions were performed using primer sets specific for the coding region of with LPS and LBP approached those seen with human alveolar macrophages incubated with a 100-fold higher concentration of the Re595 LPS.
We next sought to define the LBP dose response for enhancing LPS-induced TNFa release by alveolar macrophages. LBP dose (log g/ml)
LPS dose (log g/ml)
X , / 0 -10 -9 -8 -7
LBP dose (log g/ml)
LPS dose (log g/ml) 0 -10 -9 -8 -7
LBP dose (log g/ml) Figure 4 . The production of TNFa by human alveolar macrophages stimulated with LPS and purified rabbit LBP. The format is the same as that in Fig. 3 ng/mi) after the addition of LPS and LBP (Fig. 5 ). ( 15) . (Fig. 6) . In similar experiments, we also found no change in Fig. 8 , the antibody 28C5 inhibited TNFa production by human alveolar macrophages incubated with LPS alone, and completely blocked the enhancement ofTNFa production caused by LBP. We obtained similar results in this system when we used the 3C10 antibody. The 28C5 antibody had no effect on the production of TNFa by alveolar macrophages in response to heat-killed Staphylococcus aureus (Fig. 8) .
Effect ofLPS andLBP on intracellular calcium andpH. We next asked whether the addition of LPS or LPS/LBP complexes might cause changes in intracellular Ca"+ or pH in al- analysis to result in substantial TNFa message production by Re595 LPS alone and enhanced TNFa message production with added LBP (Fig. 3 ).
Discussion
The major goals of this study were first, to investigate whether immunoreactive LBP accumulates in fluid recovered from normal or injured human lungs, and second to investigate the effect of LBP on LPS-induced TNFa production by rabbit and human alveolar macrophages. The results indicate that immunoreactive LBP is normally present in very low concentrations in the alveolar fluid, and that its concentration rises substantially in patients with lung injury. In rabbits, LBP in lung fluids appears to originate from an extrapulmonary source, as we did not detect LBP mRNA in RNA extracted either from rabbit lung tissue or from normal or LPS-stimulated rabbit alveolar macrophages. LBP enhances the response ofhuman and rabbit alveolar macrophages to LPS. In the presence ofLBP and LPS, the maximal TNFa response by alveolar macrophages occurs earlier than with LPS alone and it also occurs at lower concentrations ofboth smooth and rough form LPS. The CD 14 receptor plays an important role in mediating the effects of LPS and LBP on alveolar macrophages, as the effects of LPS and LBP can be inhibited by anti-CD 14 monoclonal antibodies. Thus, LBP that accumulates in the lungs during lung injury may have an important regulatory effect on the response ofalveolar macrophages to endotoxin that enters the airspaces. The origin of the LBP in the lungs and the mechanism by which it enters the lungs is of considerable interest. The results of the experiments using the sensitive PCR method indicate that in rabbits the LBP present in lung lavage fluid probably derives from the liver and not from the lungs. Although alveolar macrophages are capable of producing a variety ofproteins, mRNA transcripts for LBP were not detected in normal rabbit alveolar macrophages, alveolar macrophages obtained during a systemic acute-phase response, or alveolar macrophages stimulated with LPS. In addition, we have not been able to detect LBP activity by immunoassay in the supernatants ofLPS-stimulated human or rabbit alveolar macrophages (not shown). The data confirms an earlier study in which LPB message was detected in rabbit liver RNA by Northern analysis (3). LBP (60 kD) is similar in molecular mass to albumin (67 kD), which constitutes -50% of the protein in bronchoalveolar lavage fluid (23) . When the permeability ofthe epithelial barrier in the lungs is altered, much higher molecular mass proteins, e.g., IgM (900 kD), that normally are excluded from the alveolar spaces are readily detectable in lavage fluid (9, 23, 24) . Under these conditions, proteins of the size of LBP would be expected to pass rapidly from the plasma compartment into the alveolar spaces. These lines of evidence support the interpretation that LBP is synthesized in the liver and that it accumulates in the lungs as lung epithelial permeability increases in response to injury.
Our findings have important implications for the mechanisms that regulate the production of cytokines such as TNFa within the lungs during inflammatory reactions. TNFa is thought to be an important mediator of the sepsis syndrome in animal models (25) (26) (27) , and sepsis syndrome both precedes and complicates ARDS in many patients (28) . The alveolar macrophage plays a prominent role in the response of the lung to endotoxins because it responds to LPS by producing an array of cytokines that modify the inflammatory response. In addition to TNFa, these include IL-6 (29), IL-8 (30) and to a lesser extent IL-1I3 (31, 32) . Although other cells ofthe alveolar environment, including epithelial cells (33) , fibroblasts (34), endothelial cells ( 16) , and mesothelial cells ( 35 ) have the capacity to produce some cytokines, particularly IL-8, the alveolar macrophage appears to be the primary cell in the airspace that recognizes and responds to LPS (reviewed in reference 35).
Our results suggest that LBP may play a major role in regulating the sensitivity of alveolar macrophages to LPS by both lowering the threshold and accelerating the time course ofcytokine production. A previous study showed that LBP augments the response of elicited rabbit peritoneal exudate macrophages to smooth and rough form LPS (7) . The present studies show that LBP enhances the effect of LPS on a nonelicited resident macrophage population in the lungs of both rabbits, from which the LBP was derived, and normal humans. As lung macrophages may be an important local source of TNFa during acute lung injury, the accumulation of LBP in the inflammed airspaces may provide an endogenous mechanism for amplifying or regulating the response of lung macrophages to local concentrations of LPS within the lungs.
The intracellular pathways by which LBP accentuates the effect of LPS on alveolar macrophage warrant further study. The binding ofLPS / LBP complexes to surface CD 14 on monocytes appears to be the first step in the recognition ofLPS/ LBP complexes by monocytic cells (6) . The present data confirm prior reports that CD 14 is present on alveolar macrophages (36, 37) , although the expression of CD14 on alveolar macrophages is considerably less than on peripheral blood monocytes. We found that LPS and LPS/LBP induce TNFa gene expression without affecting the density of CD14 on alveolar macrophages. We also found that specific monoclonal antibodies directed at epitopes on CD14 blocked the effect of LPS and LPS/LBP on inducing TNFa expression. Although other cell surface proteins have been identified that may contribute to the effects ofendotoxin in other systems (38) (39) (40) , our data support the primary importance ofthe CD14 pathway in mediating the response of alveolar macrophages to LPS. Previous studies showed that antibodies to CD 14 prevent the binding of LPS/ LBP bearing particles to the surface of monocyte-derived macrophages (5) and block the production of TNFa in whole blood in response to LPS (6) . Our observation that an antibody directed at CD14 inhibits the response to LPS as well as LPS/LBP strengthens the interpretation that CD14 functions as an important part ofa membrane complex that mediates the effects of LPS as well as LPS/LBP complexes.
The signals that follow binding of LPS/LBP complexes to CD14 remain uncertain. CD14 is anchored in the plasma membrane by a phosphatidylinositol tail (41 (44, 45) and tyrosine phosphorylation (46, 47) , warrant further study.
We found that one important intracellular consequence of the signaling events initiated by LPS/LBP complexes is an increase in the kinetics of TNFa mRNA message expression. In alveolar macrophages treated with LPS and LBP, TNFa mRNA appeared earlier, accumulated to higher levels, and then disappeared earlier than in macrophages treated with LPS alone. The regulation of TNFa expression is complex, and depends on promoter sequences in the TNFa gene, AU rich sequences in the 3'-untranslated region ofthe TNFa mRNA that both destabilize the mRNA and repress its translation (48, 49) , and ribonuclease activity that destroys the mRNA (50) . The earlier appearance of TNFa mRNA that we observed suggests that LBP/LPS complexes increase the rate of transcription of the TNFa gene above that seen with LPS alone, although further direct analysis of gene transcription is necessary to prove this. The observation that TNFa mRNA half-life is prolonged by LPS/LBP complexes is supported by recent experiments with elicited peritoneal macrophages (51 ) . The data do not establish whether the apparent increase in TNFa mRNA t112 is a unique effect of LBP or a consequence of increased intracellular delivery of LPS in the presence of LBP.
Although these studies indicate that LBP enhances LPSdriven TNFa production by normal alveolar macrophages, it remains to be determined whether the effect of LBP is similar for other cytokines produced by alveolar macrophages. In other studies, we have found that LBP also accelerates the production ofIL-8 by rabbit alveolar macrophages and the human monocytic cell line, THP-1. Furthermore, the effects ofLBP on immunologically activated alveolar macrophages need to be studied in detail. Because TNFa is an important mediator of the sepsis syndrome that both causes and complicates lung injury, the finding that LBP accumulates in the lung during inflammation and regulates the production of TNFa by alveolar macrophages is likely to have clinical importance. Strategies to block the effects of LBP on alveolar macrophages may be useful in limiting some types of inflammatory reactions in the lungs.
